Pure Global
NCT06411392

SBRT for Ventricular Arrhythmia

Stereotactic Antiarrhythmic Radiotherapy for Ventricular Arrhythmia in Austria (Austrian STAR)
Medical University of Graz·ClinicalTrials.gov·radiationRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Ventricular Arrythmia
Drug/Device/Intervention
Stereotactic Antiarrhythmic Radiotherapy
Study type
Interventional
Intervention type
radiation
Sponsor & location
Primary sponsor
Medical University of Graz
Location
Graz, Austria
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Feb 01, 2027
Enrollment
10 participants
Primary outcome

Safety of treatment,Efficacy of treatment

Summary

The aim of this study is to demonstrate the safety and efficacy of STAR (Stereotactic
 Antiarrhythmic Radiotherapy) in patients with VT (ventricular tachycardia) who are
 unresponsive to standard treatments. Additionally, the planned study aims to provide further
 insights into the effects of STAR on VT burden, ICD interventions, and insights regarding
 late toxicities, particularly those related to the heart, which are currently not well
 understood.

ICD-10 classifications
Ventricular tachycardiaLeft ventricular failureVentricular septal defectCardiomyopathy, unspecifiedCardiac arrhythmia, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06411392
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06411392 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Graz and is currently Recruiting. The study focuses on Ventricular Arrythmia. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.